+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Microrna"

From
microRNA (miRNA) - Global Strategic Business Report - Product Thumbnail Image

microRNA (miRNA) - Global Strategic Business Report

  • Report
  • March 2025
  • 379 Pages
  • Global
From
Global MicroRNA Market Report 2024 - Product Thumbnail Image

Global MicroRNA Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Microrna (mirna) Market 2024-2028 - Product Thumbnail Image

Microrna (mirna) Market 2024-2028

  • Report
  • August 2024
  • 166 Pages
  • Global
From
From
The Global Exosome Market: Size, Forecast, Trials, and Trends, 2024 - Product Thumbnail Image

The Global Exosome Market: Size, Forecast, Trials, and Trends, 2024

  • Report
  • September 2024
  • 351 Pages
  • Global
From
Genomic Collaboration and Licensing Deals 2018-2024 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2018-2024

  • Report
  • November 2024
  • 350 Pages
  • Global
From
From
From
RNAi Technologies and Global Markets - Product Thumbnail Image

RNAi Technologies and Global Markets

  • Report
  • June 2024
  • 118 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools. Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more